Only 85 patients initially for pivotal ph 3 FSGS. Sophisticated investors will be throwing funds at DXB, IMO.
Ann: Positive Additional Data to Support DMX-200 Development, page-10
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $211.6M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.3¢ | 37.3¢ | $572.4K | 1.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 160374 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 66473 | 8 |
View Market Depth
| Last trade - 13.47pm 30/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |